Testing effectiveness (Phase 2)Active Not RecruitingNCT03838159What this trial is testingNADIM II: Neo-Adjuvant ImmunotherapyWho this might be right forNon Small Cell Lung Cancer Fundación GECP 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT04326153What this trial is testingNeoadjuvant Immunotherapy Plus Chemotherapy for Potentially Resectable Stage IIIA/IIIB Non-Small Cell Lung CancerWho this might be right forIIIA Stage Non-small Cell Lung Cancer The First Hospital of Jilin University 30
Large-scale testing (Phase 3)Study completedNCT00002930What this trial is testingPET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by SurgeryWho this might be right forEsophageal CancerLung Cancer Memorial Sloan Kettering Cancer Center 75
Testing effectiveness (Phase 2)Study completedNCT00043108What this trial is testingCombination Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Non-Small Cell Lung CancerWho this might be right forLung Cancer Fox Chase Cancer Center 19
Not applicableLooking for participantsNCT04324151What this trial is testingPembrolizumab Combined With Double Platinum Based Chemotherapy for Potentially Resectable NSCLCWho this might be right forNon Small Cell Lung Cancer Hunan Province Tumor Hospital 70
Not applicableStudy completedNCT06448793What this trial is testingPatient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer TreatmentsWho this might be right forNon-small Cell Lung Cancer (NSCLC) Bristol-Myers Squibb 650
Large-scale testing (Phase 3)Study completedNCT00136890What this trial is testingPET Imaging in Potentially Surgically Resectable Non-small Cell Lung CancersWho this might be right forNon-small-cell Lung Carcinoma Ontario Clinical Oncology Group (OCOG) 337
Testing effectiveness (Phase 2)Looking for participantsNCT06424899What this trial is testingA Study Comparing Neoadjuvant Chemoimmunotherapy and Immuno-consolidationafter Compared With Immunoconsolidation After Radical Chemoradiotherapy for Stage III Potentially Resectable NSCLCWho this might be right forNon Small Cell Lung Cancer Zeng Jian 92
Testing effectiveness (Phase 2)Looking for participantsNCT07323056What this trial is testingNeoadjuvant Sacituzumab Tirumotecan and Limertinib for Potentially Resectable Stage Ⅲ EGFR-mutant Non-small Cell Lung CancerWho this might be right forEGFR-mutant Non-small Cell Lung CancerPotentially Resectable Shanghai Pulmonary Hospital, Shanghai, China 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT07274761What this trial is testingNeoadjuvant Sunvozertinib in Stage II-IIIB Non-small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutation.Who this might be right forPotentially Resectable EGFR Exon 20 Insertion Non-Small Cell Lung CancerNon Small Cell Lung Cancer Shanghai Pulmonary Hospital, Shanghai, China 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07775040What this trial is testingSpatially Fractionated Radiotherapy With Tislelizumab and Chemotherapy for Bulky Stage III NSCLC: A Phase II TrialWho this might be right forNon-Small Cell Lung Cancer Sichuan Cancer Hospital and Research Institute 43
Large-scale testing (Phase 3)Looking for participantsNCT07016126What this trial is testingD-BACE in Combination With Chemotherapy and Carelizumab for Resectable II-IIIA or Potentially Resectable T3-4N2 Stage IIIB NSCLCWho this might be right forNSCLC (Non-small Cell Lung Cancer) Guangdong Provincial People's Hospital 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05891080What this trial is testingNeoadjuvant Therapy With Toripalimab and JS004 Combined With Platinum-based Doublet Chemotherapy for Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer: A Randomised Controlled, Open-label, Phase 2 TrialWho this might be right forStage III Non-small Cell Lung Cancer Shanghai Pulmonary Hospital, Shanghai, China 124
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06282536What this trial is testingNeoadjuvant Therapy With Iruplinalkib for Potentially Resectable ALK Positive NSCLC: A Single Arm, Exploratory TrialWho this might be right forPotentially Resectable ALK Positive Non-Small Cell Lung Cancer Shanghai Pulmonary Hospital, Shanghai, China 20
Testing effectiveness (Phase 2)Looking for participantsNCT03694236What this trial is testingConcurrent Neoadjuvant Chemoradiotherapy Plus Durvalumab (MEDI4736) in Resectable Stage III NSCLCWho this might be right forPotentially Resectable Stage II/IIIa NSCLC Yonsei University 39
Testing effectiveness (Phase 2)UnknownNCT04304248What this trial is testingNeoadjuvant Toripalimab Plus Platinum-based Doublet for Stage III Non-small Cell Lung CancerWho this might be right forNon Small Cell Lung Cancer Hao Long 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07608159What this trial is testingNeoadjuvant SF-SBRT Plus Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC.Who this might be right forNon Small Cell Lung CancerStereotactic Body RadiotherapyNeoadjuvant Chemoimmunotherapy+1 more Shanghai Pulmonary Hospital, Shanghai, China 201
Testing effectiveness (Phase 2)Active Not RecruitingNCT04379739What this trial is testingNeoadjuvant PD-1 Antibody Plus Apatinib or Chemotherapy for Non-small Cell Lung CancerWho this might be right forNon Small Cell Lung Cancer Shanghai Pulmonary Hospital, Shanghai, China 89
Not applicableUnknownNCT06081777What this trial is testingSignificance of MRD Monitoring in Patients With Potentially Resectable Stage III Non-small Cell Lung CancerWho this might be right forNSCLC Peking University Cancer Hospital & Institute 65
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06644313What this trial is testingVebreltinib for Neoadjuvant in MET-altered Stage IIIA-IIIB (N2) Non-small Cell Lung Cancer (NSCLC)Who this might be right forPotentially Resectable MET-altered Non-Small Cell Lung Cancer Shanghai Pulmonary Hospital, Shanghai, China 31